The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease

被引:9
作者
Munteanu, Camelia [1 ]
Schwartz, Betty [2 ]
机构
[1] Univ Agr Sci & Vet Med, Fac Agr, Dept Plant Culture, Cluj Napoca 400372, Romania
[2] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, Sch Nutr Sci, IL-76100 Rehovot, Israel
关键词
liver; NAFLD; antioxidants; bile acids; AMPK; STEAROYL-COA DESATURASE-1; ACTIVATED PROTEIN-KINASE; DIET-INDUCED OBESITY; NODULAR REGENERATIVE HYPERPLASIA; HEPATIC STELLATE CELLS; E-PHOSPHOLIPID COMPLEX; NECROSIS-FACTOR-ALPHA; PLASMA HIGH-DENSITY; C-REACTIVE PROTEIN; FACTOR-KAPPA-B;
D O I
10.3390/antiox12040903
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the current review, we focused on identifying aliment compounds and micronutrients, as well as addressed promising bioactive nutrients that may interfere with NAFLD advance and ultimately affect this disease progress. In this regard, we targeted: 1. Potential bioactive nutrients that may interfere with NAFLD, specifically dark chocolate, cocoa butter, and peanut butter which may be involved in decreasing cholesterol concentrations. 2. The role of sweeteners used in coffee and other frequent beverages; in this sense, stevia has proven to be adequate for improving carbohydrate metabolism, liver steatosis, and liver fibrosis. 3. Additional compounds were shown to exert a beneficial action on NAFLD, namely glutathione, soy lecithin, silymarin, Aquamin, and cannabinoids which were shown to lower the serum concentration of triglycerides. 4. The effects of micronutrients, especially vitamins, on NAFLD. Even if most studies demonstrate the beneficial role of vitamins in this pathology, there are exceptions. 5. We provide information regarding the modulation of the activity of some enzymes related to NAFLD and their effect on this disease. We conclude that NAFLD can be prevented or improved by different factors through their involvement in the signaling, genetic, and biochemical pathways that underlie NAFLD. Therefore, exposing this vast knowledge to the public is particularly important.
引用
收藏
页数:52
相关论文
共 50 条
  • [21] Phenotyping the effect of diet on non-alcoholic fatty liver disease
    de Wit, Nicole J. W.
    Afman, Lydia A.
    Mensink, Marco
    Muller, Michael
    JOURNAL OF HEPATOLOGY, 2012, 57 (06) : 1370 - 1373
  • [22] Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats
    Li, Qiao-Ping
    Dou, Yao-Xing
    Huang, Zi-Wei
    Chen, Han-Bin
    Li, Yu-Cui
    Chen, Jian-Nan
    Liu, Yu-Hong
    Huang, Xiao-Qi
    Zeng, Hui-Fang
    Yang, Xiao-Bo
    Su, Zi-Ren
    Xie, Jian-Hui
    PHYTOMEDICINE, 2021, 85
  • [23] Non-alcoholic fatty liver disease mediates the effect of obesity on arterial hypertension
    Pirola, Carlos J.
    Sookoian, Silvia
    LIVER INTERNATIONAL, 2023, 43 (10) : 2167 - 2176
  • [24] MECHANISMS UNDERPINNING THE EFFECT OF EXERCISE ON THE NON-ALCOHOLIC FATTY LIVER DISEASE: REVIEW
    Bekheit, Mohamed
    Kamera, Blessed
    Colacino, Laura
    Dropmann, Anne
    Delibegovic, Mirela
    Almadhoob, Fatema
    Hanafy, Nemany
    Bermano, Giovanna
    Hammad, Seddik
    EXCLI JOURNAL, 2025, 24 : 238 - 266
  • [25] Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
    Wu, Dongqing
    Zhu, Huaqing
    Wang, Hua
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [26] Pathology of non-alcoholic fatty liver disease
    Bedossa, Pierre
    LIVER INTERNATIONAL, 2017, 37 : 85 - 89
  • [27] Treatment of Non-Alcoholic Fatty Liver Disease
    Dyson, Jessica
    Day, Chris
    DIGESTIVE DISEASES, 2014, 32 (05) : 597 - 604
  • [28] Mitochondria in non-alcoholic fatty liver disease
    Simoes, Ines C. M.
    Fontes, Adriana
    Pinton, Paolo
    Zischka, Hans
    Wieckowski, Mariusz R.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 95 : 93 - 99
  • [29] Pediatric Non-Alcoholic Fatty Liver Disease
    Bush, Haley
    Golabi, Pegah
    Younossi, Zobair M.
    CHILDREN-BASEL, 2017, 4 (06):
  • [30] Non-alcoholic fatty liver disease and steatohepatitis
    Par Gabriella
    Horvath Gabor
    Par Alajos
    ORVOSI HETILAP, 2013, 154 (29) : 1124 - 1134